We show here that higher expression of TRAIL DRs, in particular DR5, by α-TOS on the surface of MM cells was due to de novo synthesis rather than translocation of TRAIL receptors from cytoplasm to the plasma membrane (cfFigure 6). Here, TNFRSF10B is linked to Miyoshi myopathy.